Literature DB >> 26109510

Interaction of Anthracycline 3'-azido-epirubicin with Calf Thymus DNA via Spectral and Molecular Modeling Techniques.

Fengling Cui1, Xiaoqing Niu, Luyao Li, Pengge Zhang, Guisheng Zhang.   

Abstract

Anthracycline antibiotics are extensively applied to clinical antitumor therapy. The binding mode and mechanism of a new anthracycline 3'-azido-epirubicin (AEPI) with calf thymus deoxyribonucleic acid (ctDNA) were investigated employing multiple spectroscopy techniques in Tris-HCl buffer solution (pH 7.4). Effect of pH on the interaction was provided to determine the proper environment for whole research. Iodide quenching studies and fluorescence polarization measurement indicated that ctDNA quenched the fluorescence of AEPI significantly via intercalation binding mode. The binding constants and binding sites for the interaction were calculated. From binding constant dependence on the temperature, static quenching mechanism of AEPI by ctDNA was confirmed based on the Stern-Volmer equation. Additionally, the thermodynamic parameters for the reaction revealed that the van der Waals force and hydrogen bonding were the main acting forces in the binding process. Molecular modeling result indicated that the hydrogen bonding played a major role in the binding of AEPI to ctDNA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26109510     DOI: 10.1007/s10895-015-1601-6

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  24 in total

1.  Spectroscopic studies of interaction of chlorobenzylidine with DNA.

Authors:  W Zhong; J S Yu; W Huang; K Ni; Y Liang
Journal:  Biopolymers       Date:  2001       Impact factor: 2.505

2.  Theoretical models of pentamidine analogs activity based on their DNA minor groove complexes.

Authors:  Teresa Zołek; Dorota Maciejewska
Journal:  Eur J Med Chem       Date:  2010-01-28       Impact factor: 6.514

3.  Fluorine in medicinal chemistry: β-fluorination of peripheral pyrrolidines attached to acridine ligands affects their interactions with G-quadruplex DNA.

Authors:  Nancy H Campbell; Daniel L Smith; Anthony P Reszka; Stephen Neidle; David O'Hagan
Journal:  Org Biomol Chem       Date:  2011-01-10       Impact factor: 3.876

4.  Electrochemically-driven large amplitude pH cycling for acid-base driven DNA denaturation and renaturation.

Authors:  Yong-Chun Wang; Cong-Bin Lin; Jian-Jia Su; Ying-Ming Ru; Qiao Wu; Zhao-Bin Chen; Bing-Wei Mao; Zhao-Wu Tian
Journal:  Anal Chem       Date:  2011-05-19       Impact factor: 6.986

5.  Impact of arsenic/phosphorus substitution on the intrinsic conformational properties of the phosphodiester backbone of DNA investigated using ab initio quantum mechanical calculations.

Authors:  Elizabeth J Denning; Alexander D Mackerell
Journal:  J Am Chem Soc       Date:  2011-03-28       Impact factor: 15.419

6.  Thermodynamics of protein association reactions: forces contributing to stability.

Authors:  P D Ross; S Subramanian
Journal:  Biochemistry       Date:  1981-05-26       Impact factor: 3.162

Review 7.  Epirubicin. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer.

Authors:  A J Coukell; D Faulds
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

8.  Study of interactions of anthraquinones with DNA using ethidium bromide as a fluorescence probe.

Authors:  Chunyu Qiao; Shuyun Bi; Ying Sun; Daqian Song; Hanqi Zhang; Weihong Zhou
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2007-07-31       Impact factor: 4.098

Review 9.  Structure and function of "metalloantibiotics".

Authors:  Li-June Ming
Journal:  Med Res Rev       Date:  2003-11       Impact factor: 12.944

10.  Studies on the formation of a complex of Cu(II) with sodium 1,4-dihydroxy-9,10-anthraquinone-2-sulphonate - an analogue of the core unit of anthracycline anticancer drugs and its interaction with calf thymus DNA.

Authors:  Partha Sarathi Guin; Saurabh Das; P C Mandal
Journal:  J Inorg Biochem       Date:  2009-09-29       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.